PD-1 inhibitor (combination therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 inhibitor (combination therapy), covering 2024-10-01 to 2024-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial [Phase 2]